Related Experiment Video
Updated: Feb 2, 2026

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
Hypofractionated Concomitant Chemoradiation in Inoperable Locally Advanced Non-small Cell Lung Cancer: A Report on
M S Iqbal1, G Vashisht2, R McMenemin1
1Department of Clinical Oncology, Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Hypofractionated chemoradiation for inoperable non-small cell lung cancer shows improved survival and treatment completion rates. This regimen offers an effective option with acceptable toxicity for advanced lung cancer patients.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Oncology
Background:
- Concomitant chemoradiation is standard for inoperable non-small cell lung cancer (NSCLC).
- Hypofractionated regimens offer potential benefits in treatment delivery and patient outcomes.
Purpose of the Study:
- To analyze survival outcomes and toxicity data for hypofractionated chemoradiation in NSCLC.
- To compare findings with existing literature and phase II trial data.
Main Methods:
- Retrospective analysis of 100 patients treated with 55 Gy in 20 fractions concurrent with cisplatin vinorelbine chemotherapy.
- Survival estimation using Kaplan-Meier and Cox regression.
- Systematic literature search of Medline, Embase, and Cochrane databases.
Main Results:
- High treatment completion rates: 97% for radiotherapy, 73% for chemotherapy.
- Two-year progression-free survival (PFS) and overall survival (OS) were 49% and 58%.
- Median PFS and OS were 23.4 and 43.4 months, respectively; chemotherapy cycles received was a significant prognostic factor (P=0.02).
Conclusions:
- Hypofractionated chemoradiation demonstrated improved treatment completion and survival with acceptable toxicity compared to prior studies.
- This regimen is an effective option for locally advanced NSCLC with appropriate patient selection.
- The study provides benchmarks for efficacy and toxicity, informing future trial designs incorporating novel agents.
More Related Videos
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Data Reporting and Recording
Random and Systematic Errors
Systematic Sampling Method
Systematic sampling is one of the simplest methods...
Lung Capacity

